BNP PARIBAS FINANCIAL MARKETS - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 225 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$3,926,282
+113.2%
148,892
+39.1%
0.01%
+150.0%
Q2 2023$1,841,294
-2.9%
107,052
-6.4%
0.00%
-33.3%
Q1 2023$1,895,857
+85.0%
114,346
-15.0%
0.00%
+50.0%
Q4 2022$1,024,920
-99.9%
134,504
+3.5%
0.00%0.0%
Q2 2022$1,180,255,000
-52.9%
129,984
-47.4%
0.00%
-33.3%
Q1 2022$2,506,522,000
+471.3%
246,948
+838.9%
0.00%
+200.0%
Q4 2021$438,717,000
-59.3%
26,302
+14.4%
0.00%
-50.0%
Q3 2021$1,077,166,000
+178.7%
22,982
+262.4%
0.00%
+100.0%
Q2 2021$386,547,000
-56.7%
6,341
-56.2%
0.00%0.0%
Q1 2021$892,091,000
+12.2%
14,482
+29.5%
0.00%0.0%
Q4 2020$794,939,000
+23.6%
11,179
-34.8%
0.00%0.0%
Q3 2020$642,905,000
+127.2%
17,135
+97.5%
0.00%
Q2 2020$282,957,000
-62.1%
8,677
-66.3%
0.00%
-100.0%
Q1 2020$745,706,000
+555.2%
25,714
+691.9%
0.00%
Q4 2019$113,807,000
+60.7%
3,247
-1.5%
0.00%
Q3 2019$70,808,0003,2980.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders